Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
Oncology Today with Dr Neil Love
00:00
High-Risk Enrollment and Practical Use
Dr Sharma highlights DB11's high-risk cohort, limited ADC exposure, and stronger PCR benefit in hormone-negative tumors.
Play episode from 09:37
Transcript
